Alivus Life Sciences Ltd. NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Ltd. Live Share Price Today, Share Analysis and Chart

about

Glenmark Life Sciences is primarily engaged in the business of development, manufacture and marketing of active pharmaceutical ingredients.

Read More

1137.30 37.20 (3.38%)

50.45% Gain from 52W Low

77,312 NSE+BSE Volume

NSE 13 May, 2025 3:31 PM (IST)

Board Meeting
The next board meeting for Alivus Life Sciences Ltd. is on 15 May 2025 for the purpose of Audited Results & Final Dividend See details
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Medium Financial Strength
45.0 / 100
Expensive Valuation
26.2 / 100
Technically Neutral
53.0 / 100
Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

Alivus Life Sciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

Annual Report Mar-2024
Annual Report Mar-2023
Annual Report Mar-2022

Alivus Life Sciences Ltd. FAQ

How is Alivus Life Sciences Ltd. today?
Alivus Life Sciences Ltd. today is trading in the green, and is up by 3.38% at 1137.30.
Alivus Life Sciences Ltd. is currently trading up 3.38% on an intraday basis. In the past week the stock rose 2.37%. stock has been up 10.84% in the past quarter and rose 40.01% in the past year. You can view this in the overview section.